Lake Street Downgrades Yield10 Bioscience to Hold, Announces $0.5 Price Target
Portfolio Pulse from Benzinga Newsdesk
Lake Street analyst Ben Klieve downgrades Yield10 Bioscience (YTEN) from Buy to Hold and sets a new price target of $0.5.

February 08, 2024 | 4:50 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Yield10 Bioscience downgraded from Buy to Hold by Lake Street with a new price target of $0.5.
The downgrade from Buy to Hold suggests a less optimistic outlook on YTEN's stock by Lake Street, potentially leading to a negative short-term impact on its stock price. The new price target of $0.5, significantly lower than its current trading price, further underscores the expected downward pressure on the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100